Stock futures are little changed after S&P 500 and Dow notch worst day since October: Live updates

Stock futures are little changed after S&P 500 and Dow notch worst day since October: Live updates


Traders work on the floor at the New York Stock Exchange, Jan. 20, 2026.

Michael Nagle | Bloomberg | Getty Images

Stock futures traded near the flatline Tuesday night after major averages saw their worst day in three months.

Futures tied to the Dow Jones Industrial Average advanced 25 points, or less than 0.1%. S&P 500 futures added less than 0.1%, while Nasdaq 100 futures were marginally lower.

U.S. equities posted sharp losses in the regular session as President Donald Trump escalated his Greenland tariff threats ahead of his scheduled appearance in Davos on Wednesday. The 30-stock Dow slipped more than 870 points, or about 1.8%, while the S&P 500 lost roughly 2.1%. A drawdown in technology stocks led the selloff, with the Nasdaq Composite sliding 2.4% on the day. All three benchmark indices logged their worst daily performances since Oct. 10. The selloff also dragged the S&P 500 and the Nasdaq into negative territory for 2026.

The so-called sell America trade on Tuesday was accompanied by a spike in U.S. Treasury yields and a decline in the U.S. dollar. The 10-year Treasury yield surged and briefly topped 4.3% at the high of the day.

Trump on Tuesday doubled down on his efforts to take possession of Greenland. He threatened to impose 200% tariffs on French wines and Champagne after French President Emmanuel Macron reportedly snubbed a seat on Trump’s “Board of Peace” on Gaza. Over the weekend, Trump had announced that eight NATO members’ U.S. imports will face escalating levies “until such time as a Deal is reached for the Complete and Total purchase of Greenland.” The tariffs will start at 10% on Feb. 1 and rise to 25% on June 1, his Truth Social post said.

Danish pension operator AkademikerPension said Tuesday that it is exiting its roughly $100 million position in U.S. Treasurys because of finance concerns over U.S. debt. The move came as tensions between the U.S. and Denmark escalate on the back of Trump’s moves. European leaders, who have loudly condemned Trump’s threats, are reportedly considering using counter-tariffs and other punitive economic measures against the U.S.

“It’s not a major pullback yet, and so we do think there’s a possibility and a very realistic possibility for things to go perhaps a more negative turn before they get better, and that’s something that investors could want to position for,” Yung-Yu Ma, chief investment strategist at PNC Asset Management, said Tuesday on CNBC’s “Closing Bell.”

This week is a busy one for corporate earnings, which U.S. investors are hoping will continue to prop up the stock market this year. Netflix shares declined more than 4% in after-hours trading Tuesday after the streaming giant posted a narrow fourth-quarter earnings beat. Johnson & Johnson, Halliburton and Travelers are slated to report Wednesday.



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More